Q5101 Filgrastim - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Filgrastim

Brand Name:

Neupogen, Zarxio

Strength:

1 mcg

HCPCS:

Q5101

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Immunostimulant

Minor Drug Class:

Granulocyte Colony-Stimulating Factor

Oral (Y/N):

No

FDA Approval Year:

1991

FDA Discontinuation Year:

CMS Effective Date:

July 1, 2015

CMS Discontinuation Date:

Status:

In Use